166 related articles for article (PubMed ID: 38687371)
1. EANM position on positron emission tomography in suspected functional pituitary neuroendocrine tumours.
Van Weehaeghe D; Lapauw B; Fraioli F; Cecchin D; Verger A; Guedj E; Albert NL; Brendel M; Yakushev I; Barthel H; Traub-Weidinger T; Tolboom N; Giessen EV
Eur J Nucl Med Mol Imaging; 2024 Jul; 51(8):2367-2370. PubMed ID: 38687371
[No Abstract] [Full Text] [Related]
2. SNMMI Procedure Standard/EANM Practice Guideline for SSTR PET: Imaging Neuroendocrine Tumors.
Hope TA; Allen-Auerbach M; Bodei L; Calais J; Dahlbom M; Dunnwald LK; Graham MM; Jacene HA; Heath CL; Mittra ES; Wright CL; Fendler WP; Herrmann K; Taïeb D; Kjaer A
J Nucl Med; 2023 Feb; 64(2):204-210. PubMed ID: 36725249
[No Abstract] [Full Text] [Related]
3. Single-photon emission computed tomography tracers in the diagnostics of neuroendocrine tumors.
Pepe G; Bombardieri E; Lorenzoni A; Chiti A
PET Clin; 2014 Jan; 9(1):11-26. PubMed ID: 25029930
[TBL] [Abstract][Full Text] [Related]
4. Ectopic pituitary adenoma with empty sella in the setting of MEN-1 syndrome: detection with 68Ga-DOTANOC PET/CT.
Naswa N; Das CJ; Sharma P; Karunanithi S; Bal C; Kumar R
Jpn J Radiol; 2012 Nov; 30(9):783-6. PubMed ID: 22923184
[TBL] [Abstract][Full Text] [Related]
5. Pre- and postoperative
Tjörnstrand A; Casar-Borota O; Heurling K; Schöll M; Gjertsson P; Ragnarsson O; Filipsson Nyström H
Clin Endocrinol (Oxf); 2021 Jun; 94(6):956-967. PubMed ID: 33484167
[TBL] [Abstract][Full Text] [Related]
6. The "White paper of the European Association of Nuclear Medicine (EANM) and the European Society of Radiology (ESR) on multimodality imaging": a message from the EANM and ESR Presidents.
Cuocolo A; Adam A
Eur J Nucl Med Mol Imaging; 2007 Aug; 34(8):1145-6. PubMed ID: 17607576
[No Abstract] [Full Text] [Related]
7. EANM Focus 3: The International Conference on Molecular Imaging and Theranostics in Neuroendocrine Tumours-the consensus in a nutshell.
Kunikowska J; Ambrosini V; Herrmann K
Eur J Nucl Med Mol Imaging; 2021 May; 48(5):1276-1277. PubMed ID: 33624150
[No Abstract] [Full Text] [Related]
8. A Rare Case of Pituitary Carcinoma With Bone Metastases: 68Ga-DOTATATE PET/CT Findings.
Filizoglu N; Ozguven S
Clin Nucl Med; 2022 Mar; 47(3):e298-e299. PubMed ID: 35025796
[TBL] [Abstract][Full Text] [Related]
9. [Contributions of nuclear medicine to the diagnosis and follow-up of gastroenteropancreatic neuroendocrine tumors].
Casanovas MM
Endocrinol Nutr; 2009 Sep; 56 Suppl 3():14-9. PubMed ID: 20542215
[TBL] [Abstract][Full Text] [Related]
10. General nuclear medicine.
Ziessman HA
J Nucl Med; 2011 Nov; 52(11):20N-8N. PubMed ID: 22045712
[No Abstract] [Full Text] [Related]
11. Somatostatin receptor imaging in patients with neuroendocrine tumors: not only SPECT?
Schillaci O
J Nucl Med; 2007 Apr; 48(4):498-500. PubMed ID: 17401084
[No Abstract] [Full Text] [Related]
12. Consensus on molecular imaging and theranostics in neuroendocrine neoplasms.
Ambrosini V; Kunikowska J; Baudin E; Bodei L; Bouvier C; Capdevila J; Cremonesi M; de Herder WW; Dromain C; Falconi M; Fani M; Fanti S; Hicks RJ; Kabasakal L; Kaltsas G; Lewington V; Minozzi S; Cinquini M; Öberg K; Oyen WJG; O'Toole D; Pavel M; Ruszniewski P; Scarpa A; Strosberg J; Sundin A; Taïeb D; Virgolini I; Wild D; Herrmann K; Yao J
Eur J Cancer; 2021 Mar; 146():56-73. PubMed ID: 33588146
[TBL] [Abstract][Full Text] [Related]
13. EANM Focus 1: one small step for two men, one giant leap for a specialty.
Fanti S; Oyen WJG
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(7):1400-1401. PubMed ID: 31016331
[No Abstract] [Full Text] [Related]
14. Highlights of the EANM Congress 2011: Birmingham, UK.
de Geus-Oei LF; Zerizer I; Uebleis C; Al-Nahhas A
Eur J Nucl Med Mol Imaging; 2012 Feb; 39(2):354-68. PubMed ID: 22237847
[TBL] [Abstract][Full Text] [Related]
15. [Positron emission tomography in neuroendocrine tumours].
Biermann M; Johnsen B; Sørbye H; Følling M; Sundin A; Bach-Gansmo T
Tidsskr Nor Laegeforen; 2009 Aug; 129(15):1474-7. PubMed ID: 19690598
[TBL] [Abstract][Full Text] [Related]
16. Imaging of pituitary tumors: an update with the 5th WHO Classifications-part 1. Pituitary neuroendocrine tumor (PitNET)/pituitary adenoma.
Tsukamoto T; Miki Y
Jpn J Radiol; 2023 Aug; 41(8):789-806. PubMed ID: 36826759
[TBL] [Abstract][Full Text] [Related]
17. PET imaging in endocrine tumours.
Khan S; Lloyd C; Szyszko T; Win Z; Rubello D; Al-Nahhas A
Minerva Endocrinol; 2008 Jun; 33(2):41-52. PubMed ID: 18414356
[TBL] [Abstract][Full Text] [Related]
18. [Contemporary nuclear medicine diagnostics of neuroendocrine tumors].
Srp Arh Celok Lek; 2015; 143(1-2):108-15. PubMed ID: 25845263
[TBL] [Abstract][Full Text] [Related]
19. EANM position paper: theranostics in brain tumours-the present and the future.
Tolboom N; Verger A; Albert NL; Brendel M; Cecchin D; Fernandez PA; Fraioli F; Guedj E; Herrmann K; Traub-Weidinger T; Morbelli S; Yakushev I; Zucchetta P; Barthel H; Van Weehaeghe D
Eur J Nucl Med Mol Imaging; 2023 Dec; 51(1):202-205. PubMed ID: 37698647
[No Abstract] [Full Text] [Related]
20. Joint EANM/SNMMI/ANZSNM practice guidelines/procedure standards on recommended use of [
Lopci E; Hicks RJ; Dimitrakopoulou-Strauss A; Dercle L; Iravani A; Seban RD; Sachpekidis C; Humbert O; Gheysens O; Glaudemans AWJM; Weber W; Wahl RL; Scott AM; Pandit-Taskar N; Aide N
Eur J Nucl Med Mol Imaging; 2022 Jun; 49(7):2323-2341. PubMed ID: 35376991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
